Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 1707-1709, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hegele, R. A.
Right arrow Articles by Young, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hegele, R. A.
Right arrow Articles by Young, T. K.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2001;47:1707-1709.)
© 2001 American Association for Clinical Chemistry, Inc.


Technical Briefs

Serum C-Reactive Protein in Canadian Inuit and Its Association with Genetic Variation on Chromosome 1q21

Robert A. Hegele1a, Matthew R. Ban1 and T. Kue Young2

1 John P. Robarts Research Institute, London, Ontario, N6A 5K8 Canada

2 Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, R3E 0W3 Canada

aaddress correspondence to this author at: Blackburn Cardiovascular Genetics Laboratory, John P. Robarts Research Institute, 406-100 Perth Dr., London, Ontario, N6A 5K8 Canada; fax 519-663-3789, e-mail robert.hegele@rri.on.ca

Mortality from cardiovascular disease among Inuit living in the far north of Canada is ~40% lower than in the rest of the country (1). This might be attributable to the protection resulting from environmental factors such as dietary {omega}-3 fatty acids in Arctic fish (1). Genetic factors may also be important. For example, the thermolabile variant of methylenetetrahydrofolate reductase is much less prevalent among Inuit than among subjects of European origin (2). However, there are also paradoxical genetic findings in these people. For example, some common genetic variants associated with a higher risk of cardiovascular disease, such as the APOE E4 and AGT T235 alleles, are more prevalent among Inuit than among subjects of European origin (3). These apparent inconsistencies may be related to the fact that there are numerous determinants of susceptibility to cardiovascular disease and that these determinants may differ among ethnic groups (4). As newer determinants of cardiovascular disease risk are identified, these can be evaluated in the Inuit.

C-Reactive protein (CRP), an acute-phase reactant originally detected through its interaction with pneumococcal C polysaccharide (5), has been proposed to be a risk factor for cardiovascular disease (6). When detected with a high-sensitivity assay (6), increased serum CRP could be related to increased vascular disease risk either directly through its association with inflammation (7) or indirectly through its association with obesity and insulin resistance (8). The serum CRP concentration in the Inuit . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
J Am Coll CardiolHome page
F. G. Hage and A. J. Szalai
C-Reactive Protein Gene Polymorphisms, C-Reactive Protein Blood Levels, and Cardiovascular Disease Risk
J. Am. Coll. Cardiol., September 18, 2007; 50(12): 1115 - 1122.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.